Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082653 | SCV000114695 | benign | not specified | 2014-06-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000082653 | SCV000316173 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589562 | SCV000699950 | benign | not provided | 2016-12-04 | criteria provided, single submitter | clinical testing | Variant summary: The c.1377+20G>A in HGSNAT gene is an intronic change that involves a non-conserved nucleotide. 4/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in control population dataset of ExAC at a frequency of 0.307 (35414/115280 chrs tested). The observed frequency exceeds the estimated maximal expected allele frequency of a pathogenic variant in HGSNAT gene (0.001). The variant has been reported as Benign by a reputable database/clinical laboratory. Taking together, the variant was classified as Benign. |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625331 | SCV000744965 | benign | Mucopolysaccharidosis, MPS-III-C | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001511649 | SCV001718927 | benign | Mucopolysaccharidosis, MPS-III-C; Retinitis pigmentosa 73 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625331 | SCV001748518 | benign | Mucopolysaccharidosis, MPS-III-C | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001532800 | SCV001748519 | benign | Retinitis pigmentosa 73 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589562 | SCV001942902 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000589562 | SCV005265501 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000589562 | SCV000801588 | benign | not provided | 2015-10-26 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000082653 | SCV001919726 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000082653 | SCV001956458 | benign | not specified | no assertion criteria provided | clinical testing |